[Phase I trial and pharmacokinetics of VM 26 combined with cisplatin administered by the intraperitoneal route without mixing time].
Chatelut
E
E
Unités de pharmacologie et de pharmacocinétique cliniques, centre Claudius-Regaud, Toulouse, France.
Canal
P
P
De Forni
M
M
Chevreau
C
C
Houin
G
G
Bugat
R
R
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002945:Cisplatin / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use; D004341:Drug Evaluation; D006801:Humans; D007274:Injections, Intraperitoneal; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*; D011034:Podophyllotoxin / Q000031:analogs & derivatives*; D013713:Teniposide / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use
D013713:Teniposide; D011034:Podophyllotoxin; D002945:Cisplatin
Essai de phase I et pharmacocinetique du VM26 associé au cisplatine par voie intrapéritoneale sans temps de "barbotage" (dwell time).